Enfusion, Inc.

NYSE:ENFN

9.05 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income 6.331-13.263-282.2424.06112.656
Depreciation & Amortization 8.5876.3443.9752.2911.157
Deferred Income Tax 3.31402.66500
Stock Based Compensation 7.45824.993289.80300
Change In Working Capital -9.435-5.6-14.741-5.758-1.798
Accounts Receivables -3.679-9.031-7.493-4.216-2.79
Inventory 00-7.39200
Accounts Payables 0.365-0.8432.0440.0410.231
Other Working Capital -6.1214.274-1.9-1.5830.761
Other Non Cash Items 8.2281.6820.2221.0710.291
Operating Cash Flow 24.48314.156-0.3181.66512.306
Investing Activities:
Investments In Property Plant And Equipment -9.671-7.931-8.014-5.068-4.429
Acquisitions Net 00000
Purchases Of Investments 00000
Sales Maturities Of Investments 00000
Other Investing Activites -5.218-3.946-1.91800
Investing Cash Flow -9.671-7.931-8.014-5.068-4.429
Financing Activities:
Debt Repayment 00-100-2.1-2
Common Stock Issued 17.3220260.545166.27287.007
Common Stock Repurchased -60.447-7.959-87.846-76.634-57.45
Dividends Paid 00-3.283-4.612-11.011
Other Financing Activities -59.254-7.959-10.567-71.367-24.087
Financing Cash Flow -41.932-7.95958.84911.559-7.541
Other Information:
Effect Of Forex Changes On Cash 0.179-0.086-0.09-0.116-0.086
Net Change In Cash -26.941-1.8250.4278.040.25
Cash At End Of Period 35.60462.54564.36513.9385.898